DARA BioSciences acquires Oncogenerix - MarketLine Financial Deals

DARA BioSciences acquires Oncogenerix

DARA BioSciences acquires Oncogenerix - MarketLine Financial Deals
DARA BioSciences acquires Oncogenerix
Published Jan 17, 2012
2 pages — Published Jan 17, 2012
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

DARA BioSciences, Inc., a pharmaceutical development company, has acquired Oncogenerix, Inc., a specialty pharmaceutical company.

  
Source:
Document ID
MA95518_120119
Country
Ticker
DARA=US
Ticker
POTP=US
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "DARA BioSciences acquires Oncogenerix" Jan 17, 2012. Alacra Store. Dec 06, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/DARA-BioSciences-acquires-Oncogenerix-2052-76205>
  
APA:
MarketLine Financial Deals. (2012). DARA BioSciences acquires Oncogenerix Jan 17, 2012. New York, NY: Alacra Store. Retrieved Dec 06, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/DARA-BioSciences-acquires-Oncogenerix-2052-76205>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.